Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Ad Right Top

Latest News

Opdivo fails to meet lung cancer study goal

Bristol-Myers Squibb's blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy.

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom